Message: |
Purity 98% Dehydronandrolon Acetate CAS 2590-41-2 Pharmaceutical Intermediates
Quick Details:
Product name Dehydronandrolon Acetate
CAS No 2590-41-2
Assay >99%
Appearance Pale Yellow Solid
MF C20H26O3
MW 314.42
Standard Enterprise Standard
Description:
Dehydronandrolon acetate is a key intermediate for the synthesis of fulvestrant (faslodex) and tibolone, while the former was an anti-breast-cancer drug developed by AstraZeneca Company and the latter was a synthetic steroid marketed by Organon Company for post climacteric complains. It is an effective compound that produces quality, long-lasting muscle gains. This is because of the relatively long half-life of the drug. Users report mild side effects, with the biggest side effect being water retention.
Dehydronandrolon acetate is a key intermediate for the synthesis of fulvestrant (faslodex) and tibolone, while the former was an anti-breast-cancer drug developed by AstraZeneca Company and the latter was a synthetic steroid marketed by Organon Company for post climacteric complains. It is an effective compound that produces quality, long-lasting muscle gains. This is because of the relatively long half-life of the drug. Users report mild side effects, with the biggest side effect being water retention.
|